Log in
Show password
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 


SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

SHOP APOTHEKE EUROPE: Move to Next Generation Logistics Centre Completed.

09/16/2021 | 08:57am EDT

DGAP-News: SHOP APOTHEKE EUROPE N.V. / Key word(s): Miscellaneous
SHOP APOTHEKE EUROPE: Move to Next Generation Logistics Centre Completed.

16.09.2021 / 14:55
The issuer is solely responsible for the content of this announcement.

SHOP APOTHEKE EUROPE: Move to Next Generation Logistics Centre Completed.

Sevenum, the Netherlands, September 16 2021. With the recently completed move to its new state-of-the-art logistics hub and corporate headquarters, SHOP APOTHEKE EUROPE N.V. has passed another important milestone on its path to becoming Europe's leading customer-centric e-pharmacy platform.

The new facility with an operating area of 40,000 square meters is designed to keep pace with SHOP APOTHEKE EUROPE's steadily growing order volume. Compared to the old site in Venlo, capacity was more than doubled while a higher degree of automation means processes can run more efficiently, enabling SHOP APOTHEKE EUROPE to process and ship over 100,000 parcels a day (old site: around 39,000 parcels) or more than 35 million parcels per year to its customers in currently seven Continental European markets.

At the same time, the new building is also in alignment with the company's sustainability strategy focusing on the care of patients, employees, and the planet: It has been certified "excellent" for meeting the highest environmental standards as defined by BREEAM, the world's longest-established method for assessing, rating and certifying the sustainability of buildings. In addition, the solar panels on the rooftop will be able to provide 100% of all energy used at the site during the day. Energy for nighttime operations will be sourced from 100% renewable energies.

Stefan Feltens, CEO of SHOP APOTHEKE EUROPE, comments: "Our new logistics centre ensures that we will be able to meet our ambitious growth targets and keep up with the anticipated increasing demand of the coming years, especially in light of the introduction of electronic prescriptions, which will become mandatory in Germany in 2022. We are very happy that we have completed our move since the simultaneous operation of two logistics sites had added complexity to our processes over the past weeks and months."


SHOP APOTHEKE EUROPE is one of Europe's leading and fastest-growing online pharmacies, currently operating in Germany, Austria, France, Belgium, Italy, the Netherlands and Switzerland.

Headquartered in the Dutch logistics hub of Sevenum near Venlo with locations in Cologne, Berlin, Munich, Tongeren, Warsaw, Milan, Paris and Eindhoven, SHOP APOTHEKE EUROPE offers its customers a broad range of more than 100,000 original products at attractive prices: OTC, beauty and personal care products as well as prescription drugs, supplemented by high quality natural food and health products, low carb products and sports nutrition. Currently, more than 7 million active customers trust SHOP APOTHEKE EUROPE.

Since safe and reliable pharmaceutical advice are top priorities at SHOP APOTHEKE EUROPE, the e-pharmacy provides comprehensive pharmaceutical consulting services.

In preparation for the introduction of electronic prescriptions in Germany in summer 2021, the company will further improve the customer experience with focus on disease-specific digital medication management services following the acquisition of SMARTPATIENT in January 2021. This is a key part of SHOP APOTHEKE EUROPE's strategy to transform itself from a pure online retailer into a truly customer-centric e-pharmacy platform.

SHOP APOTHEKE EUROPE N.V. has been listed on the regulated market of the Frankfurt Stock Exchange (Prime Standard) since 2016 and is part of the SDAX stock index.


Trade and popular media:
Sven Schirmer
Tel: +49 221 99 53 44 31
Email: presse@shop-apotheke.com

Financial media:
Bettina Fries
Tel: +49 211 75 80 779
Email: presse@shop-apotheke.com

Investor relations:
Carmen Herkenrath
Tel.: +31 77 850 6109
Email: carmen.herkenrath@shop-apotheke.com

Thomas Schnorrenberg
Mobile: +49 151 465 31317
Email: presse@shop-apotheke.com

16.09.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de

Language: English
Dirk Hartogweg 14
5928 LV Venlo
Phone: 0800 - 200 800 300
Fax: 0800 - 90 70 90 20
E-mail: carmen.herkenrath@shop-apotheke.com
Internet: www.shop-apotheke-europe.com
ISIN: NL0012044747, DE000A19Y072
WKN: A2AR94, A19Y07
Indices: MDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1234010

End of News DGAP News Service

1234010  16.09.2021 


ę EQS 2021
10/14SHOP APOTHEKE EUROPE NV : Jefferies reiterates its Buy rating
10/13SHOP APOTHEKE EUROPE NV : Kepler Cheuvreux remains a Sell rating
10/07SHOP APOTHEKE EUROPE N : Nu3 Partners with French Supermarket Chain Carrefour.
10/06SHOP APOTHEKE EUROPE NV : Buy rating from Deutsche Bank
10/06SHOP APOTHEKE EUROPE NV : Berenberg remains its Buy rating
10/05SHOP APOTHEKE EUROPE NV : Morgan Stanley reiterates its Buy rating
10/05SHOP APOTHEKE EUROPE NV : Warburg Research reiterates its Buy rating
10/05SHOP APOTHEKE EUROPE NV : Receives a Buy rating from Jefferies
10/05SHOP APOTHEKE EUROPE : Strong growth of everything-but-Rx.
10/05PRESS RELEASE : SHOP APOTHEKE EUROPE: Strong growth of everything-but-Rx.
More news
Analyst Recommendations on SHOP APOTHEKE EUROPE N.V.
More recommendations
Sales 2021 1 086 M 1 260 M 1 260 M
Net income 2021 -32,7 M -37,9 M -37,9 M
Net Debt 2021 21,5 M 24,9 M 24,9 M
P/E ratio 2021 -74,8x
Yield 2021 -
Capitalization 2 459 M 2 853 M 2 853 M
EV / Sales 2021 2,28x
EV / Sales 2022 1,77x
Nbr of Employees 1 211
Free-Float 97,8%
Duration : Period :
Shop Apotheke Europe N.V. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SHOP APOTHEKE EUROPE N.V.
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus BUY
Number of Analysts 11
Last Close Price 135,90 €
Average target price 193,64 €
Spread / Average Target 42,5%
EPS Revisions
Managers and Directors
Stefan Feltens Chief Executive Officer
Jasper Eenhorst Chief Financial Officer
Bj÷rn H. S÷der Chairman-Supervisory Board
Marc Fischer Chief Information Officer
Theresa Holler Chief Operating Officer
Sector and Competitors